Clinical Trial Update: Phase II Trial of Preoperative High-dose-rate Endorectal Brachytherapy and FOLFOX Chemotherapy for Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase II trial of preoperative high-dose-rate endorectal brachytherapy with FOLFOX for rectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Rectal Cancer | Phase 2 | Status: WITHDRAWN